Create a free account to see ACCE Scores
Sign up for free to unlock scores, score breakdowns, and stock analysis.
AMPH
↓ PDF (Pro)Amphastar Pharmaceuticals Inc. Common Stock
HealthcareDrug Manufacturers - Specialty & GenericUnited StatesNASDAQ
$23.33
+2.59%today
MKT CAP
$1.1B
+8.7% · 1Y
Full Financials
Trailing P/E11.8x
Forward P/E6.9x
EV/EBITDA-
Price/Sales-
Dividend Yield-
Revenue Growth YoY-
Earnings Growth YoY-
Revenue Growth QoQ-4.5%
5y Revenue CAGR+13.0%
5y Earnings CAGR+2.4%
Gross Margin-
Operating Margin-
Net Margin-
ROE-
Debt / Equity-
Free Cash Flow-
Insider Ownership29.3%
Institutional Ownership78.1%
Short % of Float18.14%
Days to Cover7.8d
1 Week+6.3%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
| Ticker | Cap | Score | P/E | Fwd P/E | EV/EBITDA | ROE | Gross | D/E | Div |
|---|---|---|---|---|---|---|---|---|---|
| XERS | $1.1B | 60 | 94.7 | 17.0 | - | - | - | - | 0.00% |
| ALVO | $1.1B | 42 | 35.1 | 19.2 | - | - | - | - | 0.00% |
| EVO | $1.2B | 5 | - | - | - | - | - | - | 0.00% |
| CRON | $990M | 5 | - | - | - | - | - | - | 0.00% |
| COLL | $1.2B | 82 | 22.7 | 5.6 | - | - | - | - | 0.00% |
| PCRX | $937M | 58 | 193.0 | 7.0 | - | - | - | - | 0.00% |
Peers selected by sector + industry + nearest market cap. Best in column highlighted green, worst red.
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Recent Alerts
No alerts yet for AMPH.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.